Philip Van Damme

EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force

Peter M. Andersen, Sharon Abrahams, Gian Domenico Borasio et al. · European Journal of Neurology · 2011 · 1.1K citations

Medicine, Neurology, Clinical Neuroscience +15

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

Wouter van Rheenen, Aleksey Shatunov, Annelot M. Dekker et al. · Nature Genetics · 2016 · 628 citations · Full text

Life Sciences, Genetics, Neuroscience +17

Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics

Steven Boeynaems, Elke Bogaert, Dénes Kovács et al. · Molecular Cell · 2017 · 545 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs

Jie Jiang, Qiang Zhu, Tania F. Gendron et al. · Neuron · 2016 · 540 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15